Assessing Exclusive Breastfeeding Practice

NCT05959460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2024-04-02

No results posted yet for this study

Summary

This study was a longitudinal design. The questionnaire on exclusive breastfeeding was administered and was validated against the deuterium oxide dose-to-mother technique to assess human milk intake of babies aged 3 and 6 mo.

Conditions

  • Exclusive Breastfeeding
  • Human Milk
  • Breast Milk

Interventions

OTHER

Deuterium dose-to-mother method for assessing breastfeeding

Exclusive breastfeeding practice was compared between maternal recall and the deuterium dose-to-mother method.

Sponsors & Collaborators

  • Pakistan Institute of Nuclear Science and Technology (PINSTECH)

    collaborator OTHER_GOV
  • Faculty of Medicine, University of Ruhuna, Sri Lanka

    collaborator UNKNOWN
  • National Institute of Nutrition, Vietnam

    collaborator OTHER_GOV
  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER
  • International Atomic Energy Agency

    collaborator OTHER_GOV
  • St. John's Research Institute

    collaborator OTHER
  • National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

    collaborator OTHER
  • Research Organization for Nuclear Energy-BRIN Indonesia

    collaborator UNKNOWN
  • National University of Malaysia

    collaborator OTHER
  • National Center for Maternal and Child Health, Mongolia

    collaborator UNKNOWN
  • Mahidol University

    lead OTHER

Principal Investigators

  • Tippawan Pongcharoen, PhD · Mahidol U

Eligibility

Min Age
3 Months
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-12-31
Completion
2020-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959460 on ClinicalTrials.gov